Helsinki, September 2025 — MVision AI, a global provider of AI-powered solutions for radiotherapy planning, has signed a distribution agreement with Meditest, a French specialist in quality assurance for medical imaging, nuclear medicine, and radiotherapy. The partnership expands MVision AI’s reach in France, supported by Meditest’s long-standing expertise in radiation QA and equipment calibration.
Founded in 1984 and based in Buc, Meditest supports hospitals and cancer centers across France with QA equipment, calibration, and service expertise. The company is known for pairing innovation with safety to help clinical teams balance dose, quality, and performance.
“France has a highly advanced oncology ecosystem. By combining Meditest’s on-the-ground experience with our AI platform, we can help departments standardize contouring and accelerate planning—without compromising clinical rigor,” said Mahmudul Hasan, Executive Director and Founder of MVision AI.
MVision AI’s GBS™ (Guideline-Based Segmentation) Suite brings a unified approach to standardized, AI-supported contouring. The suite includes Contour+ for auto-contouring, Verify for contour comparison, and Guide for training and guideline familiarization. MVision AI also offers Dose+, an AI-guided plan optimization solution that provides patient-specific dose predictions to support faster, more consistent planning. Together, these tools streamline workflows and promote consistency across clinics.
“At Meditest, our purpose is simple: innovation with safety,” said Thibaut Baudson, directeur general of Meditest. “Partnering with MVision AI lets us bring proven, workflow-enhancing AI tools to radiotherapy teams across France, for patients’ benefit.”
MVision AI and Meditest will focus on expanding clinical access, delivering hands-on support, and helping hospitals and cancer centers implement AI technologies with confidence. The goal is better planning. And ultimately, better care.
About Meditest
Meditest is a France-based provider of quality assurance solutions for medical imaging, nuclear medicine, and radiotherapy. The company supports healthcare providers with equipment, calibration, and services that advance measurement reliability and clinical performance. Learn more at www.meditest.fr.
About MVision AI
MVision AI is a pioneering provider of AI-powered software for radiotherapy treatment planning. The company offers cloud-based tools that support same-day planning through standardization and workflow automation. MVision AI’s solutions are trusted by clinics in more than 20 countries and have supported the treatment of over 200,000 cancer patients globally. Learn more at www.mvision.ai.